290 related articles for article (PubMed ID: 23382356)
21. Anticentromere antibodies identify patients with Sjögren's syndrome and autoimmune overlap syndrome.
Salliot C; Gottenberg JE; Bengoufa D; Desmoulins F; Miceli-Richard C; Mariette X
J Rheumatol; 2007 Nov; 34(11):2253-8. PubMed ID: 17937465
[TBL] [Abstract][Full Text] [Related]
22. Prognostic factors for the clinical severity of keratoconjunctivitis sicca in patients with Sjogren's syndrome.
Chung JK; Kim MK; Wee WR
Br J Ophthalmol; 2012 Feb; 96(2):240-5. PubMed ID: 21558290
[TBL] [Abstract][Full Text] [Related]
23. Increased severity of lower urinary tract symptoms and daytime somnolence in primary Sjögren's syndrome.
Walker J; Gordon T; Lester S; Downie-Doyle S; McEvoy D; Pile K; Waterman S; Rischmueller M
J Rheumatol; 2003 Nov; 30(11):2406-12. PubMed ID: 14677185
[TBL] [Abstract][Full Text] [Related]
24. Serological profiles in subgroups of patients with Sjögren's syndrome.
Manoussakis MN; Tzioufas AG; Pange PJ; Moutsopoulos HM
Scand J Rheumatol Suppl; 1986; 61():89-92. PubMed ID: 3473654
[TBL] [Abstract][Full Text] [Related]
25. The Prevalence of Sjögren's Syndrome in Rheumatoid Arthritis Patients and Their Clinical Features.
Kim H; Cho SK; Kim HW; Han J; Kim Y; Hwang KG; Sung YK
J Korean Med Sci; 2020 Nov; 35(45):e369. PubMed ID: 33230982
[TBL] [Abstract][Full Text] [Related]
26. Sjögren's syndrome associated with systemic lupus erythematosus: clinical and laboratory profiles and comparison with primary Sjögren's syndrome.
Manoussakis MN; Georgopoulou C; Zintzaras E; Spyropoulou M; Stavropoulou A; Skopouli FN; Moutsopoulos HM
Arthritis Rheum; 2004 Mar; 50(3):882-91. PubMed ID: 15022331
[TBL] [Abstract][Full Text] [Related]
27. Serologic profile and clinical markers of Sjögren syndrome in patients with rheumatoid arthritis.
Oliveira HF; de Souza TR; Carvalho CN; Duarte A; Carvalho AT; Leão JC; Gueiros LA
Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Jun; 119(6):628-35. PubMed ID: 25956216
[TBL] [Abstract][Full Text] [Related]
28. [Primary Sjögren's syndrome: clinical and immunologic study of 80 patients].
Ramos M; Cervera R; García-Carrasco M; Miret C; Muñoz FJ; Espinosa G; Font J; Ingelmo M
Med Clin (Barc); 1997 May; 108(17):652-7. PubMed ID: 9312582
[TBL] [Abstract][Full Text] [Related]
29. Prediction of Sjögren's Syndrome Years Before Diagnosis and Identification of Patients With Early Onset and Severe Disease Course by Autoantibody Profiling.
Theander E; Jonsson R; Sjöström B; Brokstad K; Olsson P; Henriksson G
Arthritis Rheumatol; 2015 Sep; 67(9):2427-36. PubMed ID: 26109563
[TBL] [Abstract][Full Text] [Related]
30. Clinical evaluation of anti-mutated citrullinated vimentin by ELISA in rheumatoid arthritis.
Soós L; Szekanecz Z; Szabó Z; Fekete A; Zeher M; Horváth IF; Dankó K; Kapitány A; Végvári A; Sipka S; Szegedi G; Lakos G
J Rheumatol; 2007 Aug; 34(8):1658-63. PubMed ID: 17611988
[TBL] [Abstract][Full Text] [Related]
31. Elevated IgG4 serum levels among primary Sjögren's syndrome patients: do they unmask underlying IgG4-related disease?
Mavragani CP; Fragoulis GE; Rontogianni D; Kanariou M; Moutsopoulos HM
Arthritis Care Res (Hoboken); 2014 May; 66(5):773-7. PubMed ID: 25100215
[TBL] [Abstract][Full Text] [Related]
32. Epstein-Barr virus, methotrexate, and lymphoma in patients with rheumatoid arthritis and primary Sjögren's syndrome: case series.
Dawson TM; Starkebaum G; Wood BL; Willkens RF; Gown AM
J Rheumatol; 2001 Jan; 28(1):47-53. PubMed ID: 11196542
[TBL] [Abstract][Full Text] [Related]
33. Clinical and serological heterogeneity in patients with anticentromere antibodies.
Miyawaki S; Asanuma H; Nishiyama S; Yoshinaga Y
J Rheumatol; 2005 Aug; 32(8):1488-94. PubMed ID: 16078324
[TBL] [Abstract][Full Text] [Related]
34. [Difficulties in differential diagnosis of Sjögren's syndrome and systemic lupus erythematosus].
Krawiec P; Batko B; Skura A; Adamek-Guzik T; Cześnikiewicz-Guzik M; Krzanowski M; Rydz-Stryszowska I; Ryszawa N; Guzik TJ
Przegl Lek; 2006; 63(5):278-83. PubMed ID: 17036505
[TBL] [Abstract][Full Text] [Related]
35. Impaired degradation and aberrant phagocytosis of necrotic cell debris in the peripheral blood of patients with primary Sjögren's syndrome.
Fragoulis GE; Vakrakou AG; Papadopoulou A; Germenis A; Kanavakis E; Moutsopoulos HM; Manoussakis MN
J Autoimmun; 2015 Jan; 56():12-22. PubMed ID: 25228497
[TBL] [Abstract][Full Text] [Related]
36. Development of autoimmune arthritis with aging via bystander T cell activation in the mouse model of Sjögren's syndrome.
Kobayashi M; Yasui N; Ishimaru N; Arakaki R; Hayashi Y
Arthritis Rheum; 2004 Dec; 50(12):3974-84. PubMed ID: 15593201
[TBL] [Abstract][Full Text] [Related]
37. Magnetic resonance imaging of the parotid gland in patients with Sjögren's syndrome.
Späth M; Krüger K; Dresel S; Grevers G; Vogl T; Schattenkirchner M
J Rheumatol; 1991 Sep; 18(9):1372-8. PubMed ID: 1757940
[TBL] [Abstract][Full Text] [Related]
38. Anti-p53 antibodies are rarely detected in serum of patients with rheumatoid arthritis and Sjögren's syndrome.
Mariette X; Sibilia J; Delaforge C; Bengoufa D; Brouet JC; Soussi T
J Rheumatol; 1999 Aug; 26(8):1672-5. PubMed ID: 10451060
[TBL] [Abstract][Full Text] [Related]
39. Elevated levels of soluble CD40 ligand (sCD40L) in serum of patients with systemic autoimmune diseases.
Goules A; Tzioufas AG; Manousakis MN; Kirou KA; Crow MK; Routsias JG
J Autoimmun; 2006 May; 26(3):165-71. PubMed ID: 16621447
[TBL] [Abstract][Full Text] [Related]
40. Sjögren's syndrome in childhood.
Anaya JM; Ogawa N; Talal N
J Rheumatol; 1995 Jun; 22(6):1152-8. PubMed ID: 7674246
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
